Memantine and Donepezil Hydrochlorides Extended-release
NDC 69238-1553, Memantine and Donepezil, capsule, extended release, from Amneal Pharmaceuticals NY LLC.
- Product NDC
- 69238-1553
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208328
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1553 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEMANTINE HYDROCHLORIDE21 mg/1
- DONEPEZIL HYDROCHLORIDE10 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]; N-methyl-D-aspartate Receptor Antagonist [EPC]; NMDA Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69238-1553-3 | 69238155303 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69238-1553-3) |
| 69238-1553-9 | 69238155309 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69238-1553-9) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2335950c-be3b-4248-ad04-e9763aee47d2
Use it
Look up 69238-1553 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69238-1553 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69238-1553. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.